Lian Wei-Shiung, Wang Feng-Sheng, Chen Yu-Shan, Tsai Ming-Hsien, Chao How-Ran, Jahr Holger, Wu Re-Wen, Ko Jih-Yang
Core Laboratory for Phenomics and Diagnostics, Department of Medical Research and Chang Gung University College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
Biomedicines. 2022 Apr 6;10(4):860. doi: 10.3390/biomedicines10040860.
Osteoporosis and osteoarthritis account for the leading causes of musculoskeletal dysfunction in older adults. Senescent chondrocyte overburden, inflammation, oxidative stress, subcellular organelle dysfunction, and genomic instability are prominent features of these age-mediated skeletal diseases. Age-related intestinal disorders and gut dysbiosis contribute to host tissue inflammation and oxidative stress by affecting host immune responses and cell metabolism. Dysregulation of gut microflora correlates with development of osteoarthritis and osteoporosis in humans and rodents. Intestinal microorganisms produce metabolites, including short-chain fatty acids, bile acids, trimethylamine N-oxide, and liposaccharides, affecting mitochondrial function, metabolism, biogenesis, autophagy, and redox reactions in chondrocytes and bone cells to regulate joint and bone tissue homeostasis. Modulating the abundance of and , or the ratio of Firmicutes and Bacteroidetes, in the gut microenvironment by probiotics or fecal microbiota transplantation is advantageous to suppress age-induced chronic inflammation and oxidative damage in musculoskeletal tissue. Supplementation with gut microbiota-derived metabolites potentially slows down development of osteoarthritis and osteoporosis. This review provides latest molecular and cellular insights into the biological significance of gut microorganisms and primary and secondary metabolites important to cartilage and bone integrity. It further highlights treatment options with probiotics or metabolites for modulating the progression of these two common skeletal disorders.
骨质疏松症和骨关节炎是老年人肌肉骨骼功能障碍的主要原因。衰老的软骨细胞负担过重、炎症、氧化应激、亚细胞器功能障碍和基因组不稳定是这些与年龄相关的骨骼疾病的突出特征。与年龄相关的肠道疾病和肠道菌群失调通过影响宿主免疫反应和细胞代谢,导致宿主组织炎症和氧化应激。肠道微生物群的失调与人类和啮齿动物骨关节炎和骨质疏松症的发展相关。肠道微生物产生包括短链脂肪酸、胆汁酸、氧化三甲胺和脂多糖在内的代谢产物,影响软骨细胞和骨细胞中的线粒体功能、代谢、生物合成、自噬和氧化还原反应,以调节关节和骨组织的稳态。通过益生菌或粪便微生物群移植调节肠道微环境中厚壁菌门和拟杆菌门的丰度或其比例,有利于抑制肌肉骨骼组织中年龄诱导的慢性炎症和氧化损伤。补充肠道微生物群衍生的代谢产物可能会减缓骨关节炎和骨质疏松症的发展。本综述提供了关于肠道微生物以及对软骨和骨完整性重要的初级和次级代谢产物的生物学意义的最新分子和细胞见解。它进一步强调了使用益生菌或代谢产物来调节这两种常见骨骼疾病进展的治疗选择。